Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
4-Methoxydalbergione triggers ferroptosis in bladder cancer by suppressing the AKT/mTOR/GPX4 axis
Related
- Targeting host ferroptosis in cancer cachexia: Tumor-immune triggers, tissue wasting, and the therapeutic paradox
- Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II
- CST1 stabilizes GPX4 to suppress ferroptosis and promote bladder cancer progression
- SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis
- The novel biguanide derivative 4C synergizes with talazoparib by inducing ferroptosis via the SREBP1/FASN/ SLC7A11/GPX4 axis in bladder cancer
BibTeX
@article{li20264methoxydalbergione,
title = {{4-Methoxydalbergione triggers ferroptosis in bladder cancer by suppressing the AKT/mTOR/GPX4 axis}},
author = {Ran Li and Tingting Luo and Ting Tao and Xuehui Li and Haiyan Zhou and Taohong Su and Changqiong Xu and Liqiong Xia and Haifang Du},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-75265-x},
url = {https://www.nature.com/articles/s41598-026-75265-x},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - 4-Methoxydalbergione triggers ferroptosis in bladder cancer by suppressing the AKT/mTOR/GPX4 axis
AU - Ran Li
AU - Tingting Luo
AU - Ting Tao
AU - Xuehui Li
AU - Haiyan Zhou
AU - Taohong Su
AU - Changqiong Xu
AU - Liqiong Xia
AU - Haifang Du
PY - 2026
DA - 2026/10/12
JO - Scientific Reports
DO - 10.1038/s41598-026-75265-x
UR - https://www.nature.com/articles/s41598-026-75265-x
SN - 2045-2322
ER -